ArticleCancers2022

Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals.

Tahmina Nasrin Poly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.